Goodwin Investment Advisory Abb Vie Inc. Transaction History

Goodwin Investment Advisory

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $61,530 - $70,108	385 New	385 $70,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $51,670 - $59,263	385 New	385 $52,000
Q2 2022 Aug 16, 2022	SELL	$137.62 - $174.96 $58,901 - $74,882	-428 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $43,289 - $53,710	328 Added 328.0%	428 $69,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $10,743 - $13,593	100 New	100 $14,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Goodwin Investment Advisory, based on Form 13F filings with the SEC.

Stay updated on Goodwin Investment Advisory with notifications on news.